Leonteq Securities AG acquired a new position in Cigna Group (NYSE:CI – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 2,443 shares of the health services provider’s stock, valued at approximately $672,000.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. OLD National Bancorp IN increased its stake in shares of Cigna Group by 3.7% in the fourth quarter. OLD National Bancorp IN now owns 1,031 shares of the health services provider’s stock worth $284,000 after purchasing an additional 37 shares in the last quarter. Physician Wealth Advisors Inc. increased its stake in shares of Cigna Group by 1.5% in the third quarter. Physician Wealth Advisors Inc. now owns 2,712 shares of the health services provider’s stock worth $782,000 after purchasing an additional 41 shares in the last quarter. Cookson Peirce & Co. Inc. increased its stake in shares of Cigna Group by 0.8% in the third quarter. Cookson Peirce & Co. Inc. now owns 4,953 shares of the health services provider’s stock worth $1,428,000 after purchasing an additional 41 shares in the last quarter. Signet Financial Management LLC increased its stake in shares of Cigna Group by 0.6% in the third quarter. Signet Financial Management LLC now owns 7,459 shares of the health services provider’s stock worth $2,150,000 after purchasing an additional 41 shares in the last quarter. Finally, Palumbo Wealth Management LLC grew its stake in Cigna Group by 2.3% during the third quarter. Palumbo Wealth Management LLC now owns 1,927 shares of the health services provider’s stock valued at $524,000 after acquiring an additional 43 shares in the last quarter. 86.99% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling at Cigna Group
In other Cigna Group news, CEO David Cordani sold 201,878 shares of the stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the completion of the transaction, the chief executive officer owned 34,337 shares in the company, valued at $10,054,560.34. This trade represents a 85.46% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole S. Jones sold 2,307 shares of the stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $666,515.37. Following the transaction, the insider owned 32,647 shares of the company’s stock, valued at $9,432,044.77. This trade represents a 6.60% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 205,904 shares of company stock worth $60,277,068 over the last 90 days. 0.60% of the stock is owned by insiders.
Cigna Group Stock Performance
Cigna Group (NYSE:CI – Get Free Report) last released its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, beating the consensus estimate of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The business had revenue of $68.52 billion during the quarter, compared to analyst estimates of $66.29 billion. During the same quarter last year, the business earned $6.74 earnings per share. Cigna Group’s quarterly revenue was up 4.6% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, sell-side analysts forecast that Cigna Group will post 30.39 earnings per share for the current fiscal year.
Cigna Group Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be given a dividend of $1.56 per share. The ex-dividend date is Thursday, June 4th. This represents a $6.24 annualized dividend and a yield of 2.2%. Cigna Group’s dividend payout ratio (DPR) is 26.45%.
Analyst Upgrades and Downgrades
Several research firms recently weighed in on CI. Mizuho set a $330.00 target price on shares of Cigna Group in a research note on Friday, May 1st. Truist Financial raised their target price on shares of Cigna Group from $320.00 to $350.00 and gave the company a “buy” rating in a research note on Tuesday, February 17th. Wells Fargo & Company raised their target price on shares of Cigna Group from $300.00 to $305.00 and gave the company an “equal weight” rating in a research note on Friday, May 1st. Piper Sandler cut their target price on shares of Cigna Group from $374.00 to $370.00 and set an “overweight” rating for the company in a research note on Tuesday, March 3rd. Finally, Cantor Fitzgerald raised their target price on shares of Cigna Group from $325.00 to $340.00 and gave the company an “overweight” rating in a research note on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Cigna Group currently has an average rating of “Moderate Buy” and an average target price of $339.80.
Check Out Our Latest Stock Report on Cigna Group
Cigna Group Company Profile
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Featured Articles
- Five stocks we like better than Cigna Group
- SpaceX IPO: Opportunity? Or the Ultimate Hype Trade?
- CAVA Group’s Stock Looks Delicious After Strong Earnings
- Lowe’s Finds Support at $215 After Q1 Earnings Sell-Off
- Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
